Keyword Analysis & Research: vectarion

wikipedia.org

https://en.wikipedia.org/wiki/Almitrine

Almitrine (marketed as Duxil by Servier) is a diphenylmethylpiperazine derivative classified as a respiratory stimulant by the ATC. It enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also pro… Formula: C₂₆H₂₉F₂N₇ Molar mass: 477.564 g·mol−1 Melting point: 181 °C (358 °F)

Formula: C₂₆H₂₉F₂N₇

Molar mass: 477.564 g·mol−1

Melting point: 181 °C (358 °F)

DA: 93 PA: 30 MOZ Rank: 100

europepmc.org

https://europepmc.org/article/MED/6373344

WebJan 1, 1983 · Abstract. In a previous six month study almitrine bismesylate ( Vectarion ) administration has been shown to be effective and safe in the treatment of hypoxaemic … Author: Sadoul P Publish Year: 1983

Author: Sadoul P

Publish Year: 1983

DA: 78 PA: 7 MOZ Rank: 56

pharmacompass.com

https://www.pharmacompass.com/chemistry-chemical-name/vectarion

WebJul 28, 2006 · Vectarion is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors. Learn more about its molecular formula, weight, … Exact Mass: 669.22148060 g/mol Molecular Weight: 669.8 g/mol Hydrogen Bond Acceptor Count: 15 Rotatable Bond Count: 10

Exact Mass: 669.22148060 g/mol

Molecular Weight: 669.8 g/mol

Hydrogen Bond Acceptor Count: 15

Rotatable Bond Count: 10

DA: 18 PA: 98 MOZ Rank: 98

wiley.com

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdd.2510100304

WebAbstract A double blind study utilizing orally administered almitrine bismesylate was conducted involving 36 stable chronic obstructive pulmonary disease (COPD) patients … Author: Salomon A Stavchansky, J. T. Doluisio, C. M. MacLeod, M. B. Szalkowski, R. T. Bachand, R. Heilman, T... Publish Year: 1989

Author: Salomon A Stavchansky, J. T. Doluisio, C. M. MacLeod, M. B. Szalkowski, R. T. Bachand, R. Heilman, T...

Publish Year: 1989

DA: 78 PA: 94 MOZ Rank: 31

atsjournals.org

https://www.atsjournals.org/doi/full/10.1164/rccm.200605-607CR

WebThis case series demonstrates that adults may present with a PHOX2B mutation–confirmed late-onset form of congenital central hypoventilation syndrome (CCHS), having survived … Author: Nick A. Antic, Beth A. Malow, Neale Lange, R. Doug McEvoy, Amy L. Olson, Peter Turkington, Wolfram W... Publish Year: 2006

Author: Nick A. Antic, Beth A. Malow, Neale Lange, R. Doug McEvoy, Amy L. Olson, Peter Turkington, Wolfram W...

Publish Year: 2006

DA: 93 PA: 19 MOZ Rank: 13

sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S2589537022003935

WebOct 1, 2022 · The almitrine bismesylate (Vectarion Injectable®: Les Laboratoires Servier, Suresnes, France), provided by the manufacturer, or placebo was administered by …

DA: 13 PA: 19 MOZ Rank: 72

nih.gov

https://pubmed.ncbi.nlm.nih.gov/3318971/

WebAbstract. 701 patients, age 61.9 +/- 8.3 yr (mean +/- SD), with hypoxaemic chronic obstructive airways disease (COAD) were entered into a one yr placebo-controlled …

DA: 32 PA: 53 MOZ Rank: 40

has-sante.fr

https://www.has-sante.fr/jcms/p_3242559/en/vectarion-almitrine-bismesilate

WebKey points Unfavourable opinion for reimbursement in supportive treatment in addition to mechanical ventilation in the most serious cases of acute respiratory distress syndrome …

DA: 20 PA: 63 MOZ Rank: 94

rxreasoner.com

https://www.rxreasoner.com/drugs/vectarion

WebVECTARION - Drug - RxReasoner. This brand name is authorized in France. Active ingredients. The drug VECTARION contains one active pharmaceutical ingredient (API): …

DA: 34 PA: 88 MOZ Rank: 25

nih.gov

https://pubmed.ncbi.nlm.nih.gov/2566339/

WebOne year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysis. A double blind study utilizing …

DA: 26 PA: 26 MOZ Rank: 98